...
首页> 外文期刊>Clinical and experimental allergy : >Evaluation of allergenicity of genetically modified soybean protein extract in a murine model of oral allergen-specific sensitization.
【24h】

Evaluation of allergenicity of genetically modified soybean protein extract in a murine model of oral allergen-specific sensitization.

机译:在口服过敏原特异性致敏小鼠模型中评估转基因大豆蛋白提取物的致敏性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: With the development of genetically modified crop plants there has been a growing interest in the approaches available to assess the potential allergenicity of novel gene products. For additional assessment of the potential allergenicity of expressed proteins, informative data can be generated using animal models. Soybean is one of the major source of protein in human and animal nutrition, and has also been well characterized as a major allergenic source. Advances in biotechnology have resulted in an increasing number of genetically engineered foods, and among these soybean is one of the most widespread. OBJECTIVE: To develop and characterize a murine model of IgE-mediated soybean sensitization induced by intragastric immunization, in the presence of Cholera Toxin, with wild-type soybean extract (wt-SE) or with genetically modified soybean extract (gm-SE). METHODS: Balb/c mice born in our animal facilities, from females fed on soy-free food, were fed with the same soy-free food and used in all the experiments. Mice were sensitized by gavages with soybean extracts, and allergen-specific IgE and IgG responses were studied by direct ELISA and ELISA inhibition. Antigen-specific cell proliferation and cytokine production were evaluated in spleen cell cultures. Results Sensitization with both soybean extracts induced high levels of antigen-specific IgE and IgG1 and low levels of specific IgG2a. Both wt-SE and gm-SE were able to inhibit the binding of specific IgE from mice immunized with gm-SE to the same antigen used for the ELISA coating. A comparable proliferative response was obtained with the homologous as well as with the heterologous extracts. CONCLUSION: In sensitized mice, we observed a predominantly T-helper type 2 (Th2)-type immune response, with increased soybean-specific IgE and IgG1 antibodies and a concomitant increase of IL-4 and IL-5 production. RESULTS: obtained by specific IgE ELISA inhibition and by antigen-specific T cell proliferation demonstrated that wt-SE and gm-SE shared B and T epitopes. The present murine model of soybean sensitization established by the oral route should provide valuable information about risk assessment for food allergy from new proteins of genetically modified foods.
机译:背景:随着转基因作物的发展,人们对可用于评估新基因产物潜在致敏性的方法的兴趣日益增长。为了进一步评估表达蛋白的潜在致敏性,可以使用动物模型生成信息量丰富的数据。大豆是人类和动物营养中主要的蛋白质来源之一,并且也已被很好地表征为主要的过敏原来源。生物技术的进步导致转基因食品的数量增加,其中大豆是最广泛使用的大豆之一。目的:建立和表征在霍乱毒素的存在下,用野生型大豆提取物(wt-SE)或转基因大豆提取物(gm-SE)通过胃内免疫诱导的鼠IgE介导的大豆致敏小鼠模型。方法:从我们的动物设施中出生的Balb / c小鼠,以饲喂无大豆食物的雌性喂养,饲喂相同的无大豆食物,并用于所有实验。通过管饲法用大豆提取物致敏小鼠,并通过直接ELISA和ELISA抑制研究过敏原特异性IgE和IgG应答。在脾细胞培养物中评估抗原特异性细胞增殖和细胞因子产生。结果用两种大豆提取物敏化均可诱导高水平的抗原特异性IgE和IgG1和低水平的特异性IgG2a。 wt-SE和gm-SE都能够抑制来自用gm-SE免疫的小鼠的特异性IgE与用于ELISA涂层的相同抗原的结合。同源提取物和异源提取物均获得了相当的增殖反应。结论:在致敏小鼠中,我们观察到主要是2型T辅助(Th2)型免疫应答,大豆特异性IgE和IgG1抗体增加,同时IL-4和IL-5产生增加。结果:通过特异性IgE ELISA抑制和抗原特异性T细胞增殖获得的结果表明wt-SE和gm-SE共享B和T表位。通过口服途径建立的目前的大豆致敏鼠模型应该提供有关转基因食品新蛋白对食品过敏的风险评估的有价值的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号